Sort by

Newest

Oldest

Popular

Antimicrobial resistance (AMR)
00:01:43
The importance of chemical synthesis for antimicrobial research and development
01:30:13
Hit-to-lead
00:04:00
2024: A Pivotal Year in the Fight Against AMR
00:02:57
A family's journey with neonatal sepsis
00:04:40
Strengthening antibiotic access in India
00:01:02
Implementation research for the appropriate use of, and access to, antimicrobials
01:28:45
Hit validation and characterization
00:04:57
An introduction to antibiotic research and development (R&D)
01:26:40
Exploring non-traditional antimicrobials: Insights from three cases
01:29:34
The value of surveillance data in defining the medical need for new antimicrobials
00:47:00
Progressing an antibacterial drug discovery project - an SME perspective
01:31:57
Efflux inhibitors: A strategy to tackle multidrug resistance
01:29:23
Progressing a discovery project – Criteria and challenges
01:27:10
Difficult-to-treat resistance (DTR)
00:01:16
What does the future look like if pull incentives to support antibiotic R&D are insufficient?
00:57:52
SECURE: Improving access to antibiotics through new economic models
01:02:01
What do the various non-commercial actors in the antibiotic R&D ecosystem do?
01:23:29
Putting public health needs at the centre of antibiotic drug development
00:02:29
Endpoints for antibacterial trials: microbiologic
00:02:23
Endpoints for antibacterial trials: timing of assessments
00:01:57
GARDP: An innovative public health approach to counter AMR
00:59:42
GARDP - Celebrating 5 years
00:02:57
Exploring opportunities to improve the treatment of gonorrhoea in Thailand
00:02:26
Staying one step ahead of the bug
00:02:26
The fight against drug resistant gonorrhoea
00:01:44
Lead optimization
00:03:37
Market interventions to improve access to antibiotics for resistant infections
01:00:15
Research brings hope for better antibiotic treatment for babies
00:02:27
Antibiotic shortages  causes, consequences, and solutions
00:59:11